Advertisement
Home 2016

Archives

Three years into the campaign

CDC: Tips Anti-Smoking Ad Campaign Still Having Impact

0
More than 1.8 million smokers attempted to quit smoking as a result of the 2014 ad campaign
For the seventh consecutive year

Record Number of Med School Grads Choosing Family Medicine

0
Seventh consecutive year of increase, but supply still doesn't meet demand for family doctors
A new method of repairing anterior cruciate ligament tears shows promise

Boston Children’s Hospital Unveils Novel ACL Repair Method

0
Preliminary study assessed the safety of the technique
Medicare could soon pay for a program aimed at diabetes prevention

Medicare May Soon Cover Diabetes Prevention Program

0
Expanding program within Medicare could save $2,650 over 15 months per beneficiary
Continuing their push to combat the nation's epidemic of opioid abuse

FDA Wants Generic Opioids to Be Abuse-Deterrent

0
One more step to combat the epidemic of opioid abuse
When doctors in the United States prescribe opioids for their patients

Many Doctors Prescribe Opioids for Longer Than CDC Advises

0
While 99 percent exceed the recommended three-day dosage limit, a quarter write Rx for a full month
Cinqair (reslizumab) has been approved by the U.S. Food and Drug Administration to treat severe asthma among adults 18 and older.

FDA Approves Cinqair for Severe Asthma

0
Lab-developed interleukin-5 antagonist monoclonal antibody helps reduce blood levels of eosinophils
Among U.S. high school athletes

Wrestling Wins for Most High School Athletic Skin Infections

0
Overall rate of skin infections is 2.27 per 100,000 athlete exposures; mostly bacterial and tinea
Physicians can help to identify and assist trafficking victims

AMA Encouraging Physicians to ID, Assist Victims of Trafficking

0
Physicians should be aware of warning signs such as bruises, cuts, scars; looking fearful or anxious
The U.S. Food and Drug Administration has announced that immediate-release opioid pain medications will get new boxed warnings about the dangers of misuse.

FDA Orders Enhanced Warning Labels on Opioid Pain Medications

0
New labeling rules mostly aimed at immediate-release versions of opioids